Welcome to CDC stacks |
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Catalog of immunological and microbiological reference reagents
  • Published Date:
    Revised edition 1973
Filetype[PDF-29.94 MB]


This document cannot be previewed automatically as it exceeds 5 MB
Please click the thumbnail image to view the document.
Catalog of immunological and microbiological reference reagents
Details:
  • Supporting Files:
    No Additional Files
No Related Documents.
You May Also Like:
  1. Progress Toward Hepatitis B Control — South-East Asia Region, 2016–2019
    Personal Author:
    Sandhu, Hardeep S.; Roesel, Sigrun; Sharifuzzaman, Mohammad; Chunsuttiwat, Supamit; Tohme, Rania A.;
    Published Date:
    July 31 2020
    Source:
    MMWR Morb Mortal Wkly Rep. 69(30):988-992
    Description:
    In 2015, the World Health Organization (WHO) South-East Asia Region (SEAR)* reported an estimated 40 million persons living with chronic hepatitis B virus (HBV) infection and 285,000 deaths from complications of chronic infection, cirrhosis, and hepa...
    File Type:
    Filetype[PDF - 300.60 KB]
  2. Interim guidance for rapid antigen testing for SARS-CoV-2
    Corporate Authors:
    National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.
    Published Date:
    Aug. 29, 2020
    Description:
    Updated Aug. 29, 2020Note: Antigen tests can be used in a variety of testing strategies to respond to the coronavirus disease 2019 (COVID-19) pandemic. This interim guidance is intended for clinicians who order antigen tests, receive antigen test res...
    File Type:
    Filetype[PDF - 229.59 KB]
  3. Guidance for using rapid diagnostic tests for Ebola in the United States
    Corporate Authors:
    Centers for Disease Control and Prevention (U.S.)
    Published Date:
    December 16, 2019
    Series:
    HAN ; 423
    Description:
    Distributed via the CDC Health Alert NetworkDecember 16, 2019, 1400 EST (2:00 PM EST)CDCHAN-00423In October 2019, the U.S. Food and Drug Administration (FDA) allowed marketing of the OraQuick® Ebola Rapid Antigen Test, a rapid diagnostic test (RDT) ...
    File Type:
    Filetype[PDF - 108.13 KB]
  4. Evaluation of Patient IgM and IgG Reactivity Against Multiple Antigens for Improvement of Serodiagnostic Testing for Early Lyme Disease
    Personal Author:
    Brandt, Kevin S.; Horiuchi, Kalanthe; Biggerstaff, Brad J.; Gilmore, Robert D.;
    Published Date:
    December 05 2019
    Source:
    Front Public Health. 2019; 7
    Description:
    Serologic testing is the standard for laboratory diagnosis and confirmation of Lyme disease. Serodiagnostic assays to detect antibodies against |, the agent of Lyme borreliosis, are used for detection of infection. However, serologic testing within t...
    File Type:
    Filetype[PDF - 313.64 KB]
  5. Multiplex malaria antigen detection by bead-based assay and molecular confirmation by PCR shows no evidence of Pfhrp2 and Pfhrp3 deletion in Haiti
    Personal Author:
    Herman, Camelia; Huber, Curtis S.; Jones, Sophie; Steinhardt, Laura; Plucinski, Mateusz M.; Lemoine, Jean F.; Chang, Michelle; Barnwell, John W.; Udhayakumar, Venkatachalam; Rogier, Eric;
    Published Date:
    November 27 2019
    Source:
    Malar J. 18
    Description:
    BackgroundThe Plasmodium falciparum parasite is the only human malaria that produces the histidine-rich protein 2 and 3 (HRP2/3) antigens. Currently, HRP2/3 are widely used in malaria rapid diagnostic tests (RDTs), but several global reports have rec...
    File Type:
    Filetype[PDF - 1.98 MB]